Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

CD301b⁺ dermal dendritic cells drive T helper 2 cell-mediated immunity.

Immunity | 2013

Unlike other types of T helper (Th) responses, whether the development of Th2 cells requires instruction from particular subset of dendritic cells (DCs) remains unclear. By using an in vivo depletion approach, we have shown that DCs expressing CD301b were required for the generation of Th2 cells after subcutaneous immunization with ovalbumin (OVA) along with papain or alum. CD301b⁺ DCs are distinct from epidermal or CD207⁺ dermal DCs (DDCs) and were responsible for transporting antigen injected subcutaneously with Th2-type adjuvants. Transient depletion of CD301b⁺ DCs resulted in less effective accumulation and decreased expression of CD69 by polyclonal CD4⁺ T cells in the lymph node. Moreover, despite intact cell division and interferon-γ production, CD301b⁺ DC depletion led to blunted interleukin-4 production by OVA-specific OT-II transgenic CD4⁺ T cells and significantly impaired Th2 cell development upon infection with Nippostrongylus brasiliensis. These results reveal CD301b⁺ DDCs as the key mediators of Th2 immunity.

Pubmed ID: 24076051 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAMS NIH HHS, United States
    Id: R37 AR040072
  • Agency: NIAID NIH HHS, United States
    Id: AI054359
  • Agency: NIAMS NIH HHS, United States
    Id: AR40072
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR040072
  • Agency: NIAMS NIH HHS, United States
    Id: T32 AR007107
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI054359
  • Agency: NIAMS NIH HHS, United States
    Id: P30 AR053495
  • Agency: NIAMS NIH HHS, United States
    Id: AR44076
  • Agency: NIAID NIH HHS, United States
    Id: R56 AI062428
  • Agency: NIAID NIH HHS, United States
    Id: AI062428
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI062428
  • Agency: NIAMS NIH HHS, United States
    Id: R01 AR044076

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Miltenyi Biotec (tool)

RRID:SCR_008984

An Organization portal, Antibody supplier, Service resource,

View all literature mentions